Table 1 Patient summary characteristics grouped by type and stratified by outcome.

From: Predicting remission after internet-delivered psychotherapy in patients with depression using machine learning and multi-modal data

 

No Remission

Remission

Missing

n

451

338

105

Process

 ICBT start week of year

25.8 (16.1)

24.1 (15.6)

26

 MADRS-S time of day

15:06:08 (5:10:04)

16:01:15 (4:71:03)

29

 EQ5D time to complete

141.4 (308.2)

133.96 (362.1)

31

Genetic

 PRS-IQ (p ≤ 0.00001)

0.05 (0.99)

−0.01 (1.04)

0

 PRS-IQ (p ≤ 0.001)

−0.07 (0.97)

0.08 (0.99)

0

 PRS-IQ (p ≤ 0.05)

0.00 (1.00)

0.10 (0.96)

0

 PRS-MDD (p ≤ 0.00001)

0.02 (0.98)

−0.06 (1.03)

0

 PRS-MDD (p ≤ 0.05)

−0.04 (0.88)

−0.11 (0.88)

0

 PRS-ASD (p ≤ 0.00001)

−0.00 (0.97)

0.03 (1.03)

0

 PRS-ASD (p ≤ 0.001)

−0.00 (0.97)

0.02 (1.02)

0

 PRS-ADHD (p ≤ 0.00001)

−0.08 (1.00)

0.04 (0.98)

0

 PRS-ADHD (p ≤ 0.001)

−0.04 (0.97)

−0.09 (1.00)

0

 PRS-BP (p ≤ 0.00001)

−0.07 (0.99)

0.06 (1.04)

0

 PRS-EDU (p ≤ 0.001)

0.02 (0.95)

0.11 (0.99)

0

 PRS-EDU (p ≤ 0.05)

0.07 (0.99)

0.08 (0.94)

0

 PRS-Ancestry (p ≤ 0.001)

0.01 (1.07)

−0.02 (0.93)

0

Demographic

 Age

39.0 (11.9)

37.8 (11.7)

0

 Education

4.9 (1.2)

5.2 (1.2)

2

 Work experience

311 (69)

259 (77)

2

Clinical

 Prior mild MDD

57 (13)

59 (18.0)

35

 Prior moderate MDD

96 (22)

72 (22)

35

 Previous depression episodes

5.6 (7.9)

4.1 (5.2)

0

 MADRS-S screen

26.4 (5.7)

23.3 (6.0)

0

 MADRS-S pre

24.0 (5.8)

19.85 (6.0)

0

 MADRS pre

21.8 (5.8)

19.7 (5.6)

47

 PHQ-9 pre

16.6 (5.1)

13.7 (5.1)

29

 EQ5D pre

0.6 (0.2)

0.7 (0.2)

5

 EQ5D extreme anx/dep

186 (43)

89 (27)

31

 EQ5D moderate pain

216 (50)

118 (36)

31

 LSAS screen

45.0 (25.2)

38.1 (24.3)

88

 PDSS screen

5.5 (5.6)

5.0 (5.4)

34

 AUDIT screen

5.6 (4.9)

4.8 (4.4)

2

 AUDIT-C screen

3.5 (2.1)

3.2 (2.0)

59

 CGI-S pre

3.7 (0.7)

3.6 (0.8)

111

 GSE pre

24.7 (4.9)

26.1 (5.0)

263

 Prior psy meds

0.9 (1.2)

0.6 (0.9)

0

 Current psy meds

1.3 (1.3)

0.9 (1.2)

0

 No prior psy med

139 (32)

144 (44)

35

 Any current psy med

235 (65)

147 (51)

157

 Variable sleep-wake pattern

174 (51)

109 (43)

218

 Reduced sex drive

181 (58)

131 (56)

272

 Retarded speech

28 (8)

26 (10)

207

 Reduced facial expressions

35 (10)

33 (13)

213

 Agitation

39 (11)

27 (11)

208

 GAF pre

61.1 (7.2)

62.7 (7.3)

214

  1. Data are integer count (%) or decimal mean (SD). Total sample n = 894.
  2. See Table S2 in the Appendix for a full description of variables.
  3. ADHD attention-deficit hyperactivity disorder, ASD autism spectrum disorder, AUDIT Alcohol Use Disorders Identification Test, BD bipolar disorder, CGIS Clinical Global Impression Scale, EQ5D-3L EuroQoL’s quality of life five dimension scale with three level items, EuroQoL European Quality of Life group, GAF Global Assessment of Functioning, GSS General Self-efficacy Scale, GWS genome-wide significance, ICBT internet-delivered cognitive behaviour therapy, LSAS Liebowitz Social Anxiety Scale, MADRS-S Montgomery-Åsberg Depression Rating Scale-Self report, MDD major depressive disorder, PDSS Panic Disorder Severity Scale, PRS polygenic risk score, SNP single-nucleotide polymorphism.